Maximising the ability to identify a potential blockbuster drug has never been so important in the Pharmaceutical industry.  With many of the hugely successful drugs from the 90's coming to the end of their patents, the pressure is on to develop the next big hit.  This has meant the design of strong lead compounds is a must, and new strategies are being developed for this wherever possible.

SMi's 9th Annual Advances and Progress in Drug Design conference aims to address the latest developments in drug design and offer tangible examples of these processes in practise.  Attended by senior representatives from all the leading pharmaceutical companies this conference allows you to stay ahead of the game in drug design.